Covered recipient · General Payments record
DAVID A RUSSLER-GERMAIN
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2019–2024
$45,583.66
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $11,000.00 | 1 |
| Food and Beverage | $216.13 | 4 |
| Travel and Lodging | $109.78 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $11,000.00 | 1 |
| Kite Pharma, Inc. | $144.50 | 3 |
| Genentech USA, Inc. | $71.63 | 1 |
| Acerta Pharma LLC | $69.38 | 2 |
| TAIHO ONCOLOGY, INC. | $40.40 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $31.45 | 07/25/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104524004 | CMS |
| AstraZeneca Pharmaceuticals LP | $37.93 | 10/31/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105361348 | CMS |
| Genentech USA, Inc. | $71.63 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132999675 | CMS |
| Kite Pharma, Inc. | $4.13 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612895 | CMS |
| Kite Pharma, Inc. | $130.35 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612897 | CMS |
| Kite Pharma, Inc. | $10.02 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612901 | CMS |
| Merck Sharp & Dohme LLC | $11,000.00 | 03/13/2024 | Grant | Undisputed | 01/23/2026 | 1141821171 | CMS |
| TAIHO ONCOLOGY, INC. | $17.64 | 07/25/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1137943669 | CMS |
| TAIHO ONCOLOGY, INC. | $22.76 | 10/31/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1137945180 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.